SITC Immunotherapy for the Treatment of Acute Leukemia 2026 Guideline - Key Recommendations

Clinical Guideline InSights · Oct 7, 2026 · 14m

The 2026 Immunotherapy for the Treatment of Acute Leukemia guideline, highlighting key recommendations across immunotherapy for the treatment of acute myeloid leukemia, CAR T-cell therapy, blinatumomab toxicity, and more.

Immunotherapy for the Treatment of Acute Leukemia

Society for Immunotherapy of Cancer

September 21, 2026

Guideline Summary: https://www.guidelinecentral.com/guideline/309932/

Full-Text: https://jitc.bmj.com/content/14/9/e015963